Reduced incidence of thymis lymphomas in AKR recipients of syngeneic marrow preincubated with bovine serum albumin.
D000367:Age Factors; D000818:Animals; D001853:Bone Marrow / Q000276:immunology*; D016026:Bone Marrow Transplantation; D002471:Cell Transformation, Neoplastic; D004195:Disease Models, Animal; D017707:Erythrocyte Transfusion; D004912:Erythrocytes / Q000276:immunology*; D005260:Female; D008223:Lymphoma / Q000188:drug therapy / Q000628:therapy; D008297:Male; D051379:Mice; D009368:Neoplasm Transplantation; D011830:Radiation Effects; D012710:Serum Albumin, Bovine / Q000627:therapeutic use; D013950:Thymus Gland / Q000276:immunology / Q000473:pathology; D013953:Thymus Neoplasms / Q000188:drug therapy / Q000628:therapy; D013997:Time Factors; D014184:Transplantation, Homologous
D012710:Serum Albumin, Bovine